Enzolytics Inc (OTCMKTS:ENZC) Stock In Focus After Successful Completion of an MTD Tolerability Study
It was a momentous day for Enzolytics Inc (OTCMKTS:ENZC) as the company came into the news cycle after it announced that it had been successful in completing the first phase of the animal toxicology studies into its anti-HIV product ITV-1. Trading Data On Wednesday, ENZC stock fell 1.45% to $0.0340 with 5.82 million shares, compared to its average volume of 5.75 million shares. The stock moved within a range of…